Literature DB >> 23197718

SRPK2 phosphorylates tau and mediates the cognitive defects in Alzheimer's disease.

Yi Hong1, Chi Bun Chan, Il-Sun Kwon, Xuekun Li, Mingke Song, Hyun-Pil Lee, Xia Liu, Pradoldej Sompol, Peng Jin, Hyoung-gon Lee, Shan Ping Yu, Keqiang Ye.   

Abstract

Serine-arginine protein kinases 2 (SRPK2) is a cell cycle-regulated kinase that phosphorylates serine/arginine domain-containing proteins and mediates pre-mRNA splicing with unclear function in neurons. Here, we show that SRPK2 phosphorylates tau on S214, suppresses tau-dependent microtubule polymerization, and inhibits axonal elongation in neurons. Depletion of SRPK2 in dentate gyrus inhibits tau phosphorylation in APP/PS1 mouse and alleviates the impaired cognitive behaviors. The defective LTP in APP/PS1 mice is also improved after SRPK2 depletion. Moreover, active SRPK2 is increased in the cortex of APP/PS1 mice and the pathological structures of human Alzheimer's disease (AD) brain. Therefore, our study suggests SRPK2 may contribute to the formation of hyperphosphorylated tau and the pathogenesis of AD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23197718      PMCID: PMC3518045          DOI: 10.1523/JNEUROSCI.3300-12.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  46 in total

1.  Localization of serine kinases, SRPK1 (SFRSK1) and SRPK2 (SFRSK2), specific for the SR family of splicing factors in mouse and human chromosomes.

Authors:  H Y Wang; K C Arden; J R Bermingham; C S Viars; W Lin; A D Boyer; X D Fu
Journal:  Genomics       Date:  1999-04-15       Impact factor: 5.736

2.  Regulated cellular partitioning of SR protein-specific kinases in mammalian cells.

Authors:  Jian-Hua Ding; Xiang-Yang Zhong; Jonathan C Hagopian; Marissa M Cruz; Gourisankar Ghosh; James Feramisco; Joseph A Adams; Xiang-Dong Fu
Journal:  Mol Biol Cell       Date:  2005-11-30       Impact factor: 4.138

Review 3.  Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease?

Authors:  Jürgen Götz; Lars M Ittner; Stefan Kins
Journal:  J Neurochem       Date:  2006-06-19       Impact factor: 5.372

4.  P70 S6 kinase mediates tau phosphorylation and synthesis.

Authors:  Jin-Jing Pei; Wen-Lin An; Xin-Wen Zhou; Takeshi Nishimura; Jan Norberg; Eirikur Benedikz; Jürgen Götz; Bengt Winblad
Journal:  FEBS Lett       Date:  2005-12-06       Impact factor: 4.124

5.  Tumor-suppressor PTEN affects tau phosphorylation, aggregation, and binding to microtubules.

Authors:  Xue Zhang; Feng Li; Ayelen Bulloj; Yun-Wu Zhang; Gang Tong; Zhuohua Zhang; Francesca-Fang Liao; Huaxi Xu
Journal:  FASEB J       Date:  2006-04-27       Impact factor: 5.191

6.  Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments.

Authors:  A Schneider; J Biernat; M von Bergen; E Mandelkow; E M Mandelkow
Journal:  Biochemistry       Date:  1999-03-23       Impact factor: 3.162

7.  Cdk5 Modulation of mitogen-activated protein kinase signaling regulates neuronal survival.

Authors:  Ya-Li Zheng; Bing-Sheng Li; Jyotshna Kanungo; Sashi Kesavapany; Niranjana Amin; Philip Grant; Harish C Pant
Journal:  Mol Biol Cell       Date:  2006-11-15       Impact factor: 4.138

8.  The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease.

Authors:  S Illenberger; Q Zheng-Fischhöfer; U Preuss; K Stamer; K Baumann; B Trinczek; J Biernat; R Godemann; E M Mandelkow; E Mandelkow
Journal:  Mol Biol Cell       Date:  1998-06       Impact factor: 4.138

9.  Pseudophosphorylation and glycation of tau protein enhance but do not trigger fibrillization in vitro.

Authors:  Mihaela Necula; Jeff Kuret
Journal:  J Biol Chem       Date:  2004-09-10       Impact factor: 5.157

10.  Sequential phosphorylation of tau protein by cAMP-dependent protein kinase and SAPK4/p38delta or JNK2 in the presence of heparin generates the AT100 epitope.

Authors:  Hirotaka Yoshida; Michel Goedert
Journal:  J Neurochem       Date:  2006-10       Impact factor: 5.372

View more
  21 in total

1.  7,8-dihydroxyflavone prevents synaptic loss and memory deficits in a mouse model of Alzheimer's disease.

Authors:  Zhentao Zhang; Xia Liu; Jason P Schroeder; Chi-Bun Chan; Mingke Song; Shan Ping Yu; David Weinshenker; Keqiang Ye
Journal:  Neuropsychopharmacology       Date:  2013-09-11       Impact factor: 7.853

2.  Fat mass and obesity-associated (FTO) protein regulates adult neurogenesis.

Authors:  Liping Li; Liqun Zang; Feiran Zhang; Junchen Chen; Hui Shen; Liqi Shu; Feng Liang; Chunyue Feng; Deng Chen; Huikang Tao; Tianlei Xu; Ziyi Li; Yunhee Kang; Hao Wu; Lichun Tang; Pumin Zhang; Peng Jin; Qiang Shu; Xuekun Li
Journal:  Hum Mol Genet       Date:  2017-07-01       Impact factor: 6.150

3.  Distinct chronology of neuronal cell cycle re-entry and tau pathology in the 3xTg-AD mouse model and Alzheimer's disease patients.

Authors:  Alex C Hradek; Hyun-Pil Lee; Sandra L Siedlak; Sandy L Torres; Wooyoung Jung; Ashley H Han; Hyoung-gon Lee
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

4.  Delta-Secretase Phosphorylation by SRPK2 Enhances Its Enzymatic Activity, Provoking Pathogenesis in Alzheimer's Disease.

Authors:  Zhi-Hao Wang; Pai Liu; Xia Liu; Fredric P Manfredsson; Ivette M Sandoval; Shan Ping Yu; Jian-Zhi Wang; Keqiang Ye
Journal:  Mol Cell       Date:  2017-08-17       Impact factor: 17.970

5.  Stress Granules Determine the Development of Obesity-Associated Pancreatic Cancer.

Authors:  Alexandra Redding; Hannah Hoag-Lee; Guillaume Fonteneau; Edward S Sim; Stefan Heinrich; Matthias M Gaida; Elda Grabocka
Journal:  Cancer Discov       Date:  2022-08-05       Impact factor: 38.272

Review 6.  Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons.

Authors:  Ravi Rajmohan; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

7.  Multivariate analysis of genome-wide data to identify potential pleiotropic genes for five major psychiatric disorders using MetaCCA.

Authors:  XiaoCan Jia; YongLi Yang; YuanCheng Chen; ZhiWei Cheng; Yuhui Du; Zhenhua Xia; Weiping Zhang; Chao Xu; Qiang Zhang; Xin Xia; HongWen Deng; XueZhong Shi
Journal:  J Affect Disord       Date:  2018-07-17       Impact factor: 4.839

8.  Heterozygous Variants in KMT2E Cause a Spectrum of Neurodevelopmental Disorders and Epilepsy.

Authors:  Anne H O'Donnell-Luria; Lynn S Pais; Víctor Faundes; Jordan C Wood; Abigail Sveden; Victor Luria; Rami Abou Jamra; Andrea Accogli; Kimberly Amburgey; Britt Marie Anderlid; Silvia Azzarello-Burri; Alice A Basinger; Claudia Bianchini; Lynne M Bird; Rebecca Buchert; Wilfrid Carre; Sophia Ceulemans; Perrine Charles; Helen Cox; Lisa Culliton; Aurora Currò; Florence Demurger; James J Dowling; Benedicte Duban-Bedu; Christèle Dubourg; Saga Elise Eiset; Luis F Escobar; Alessandra Ferrarini; Tobias B Haack; Mona Hashim; Solveig Heide; Katherine L Helbig; Ingo Helbig; Raul Heredia; Delphine Héron; Bertrand Isidor; Amy R Jonasson; Pascal Joset; Boris Keren; Fernando Kok; Hester Y Kroes; Alinoë Lavillaureix; Xin Lu; Saskia M Maas; Gustavo H B Maegawa; Carlo L M Marcelis; Paul R Mark; Marcelo R Masruha; Heather M McLaughlin; Kirsty McWalter; Esther U Melchinger; Saadet Mercimek-Andrews; Caroline Nava; Manuela Pendziwiat; Richard Person; Gian Paolo Ramelli; Luiza L P Ramos; Anita Rauch; Caitlin Reavey; Alessandra Renieri; Angelika Rieß; Amarilis Sanchez-Valle; Shifteh Sattar; Carol Saunders; Niklas Schwarz; Thomas Smol; Myriam Srour; Katharina Steindl; Steffen Syrbe; Jenny C Taylor; Aida Telegrafi; Isabelle Thiffault; Doris A Trauner; Helio van der Linden; Silvana van Koningsbruggen; Laurent Villard; Ida Vogel; Julie Vogt; Yvonne G Weber; Ingrid M Wentzensen; Elysa Widjaja; Jaroslav Zak; Samantha Baxter; Siddharth Banka; Lance H Rodan
Journal:  Am J Hum Genet       Date:  2019-05-09       Impact factor: 11.043

9.  Subcellular transcriptome alterations in a cell culture model of spinal muscular atrophy point to widespread defects in axonal growth and presynaptic differentiation.

Authors:  Lena Saal; Michael Briese; Susanne Kneitz; Michael Glinka; Michael Sendtner
Journal:  RNA       Date:  2014-09-22       Impact factor: 4.942

Review 10.  Neuroprotective function of 14-3-3 proteins in neurodegeneration.

Authors:  Tadayuki Shimada; Alyson E Fournier; Kanato Yamagata
Journal:  Biomed Res Int       Date:  2013-12-02       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.